These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19716599)

  • 21. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S
    Am J Respir Crit Care Med; 2008 Aug; 178(4):322-3. PubMed ID: 18676961
    [No Abstract]   [Full Text] [Related]  

  • 22. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Often test the lungs of your patients! "Each patient should know his FEV1 value"].
    MMW Fortschr Med; 2003 May; 145(19):57. PubMed ID: 12813989
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of mild chronic obstructive pulmonary disease].
    Izquierdo Alonso JL; Rodríguez González-Moro JM
    Med Clin (Barc); 2008 May; 130(17):661-5. PubMed ID: 18501130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Air trapping in COPD].
    Mitfessel H
    Krankenpfl J; 2005; 43(4-6):117. PubMed ID: 16171063
    [No Abstract]   [Full Text] [Related]  

  • 26. Tiotropium in chronic obstructive pulmonary disease.
    Sierra-Sánchez JF; Alegre-del Rey EJ; Cobo I
    N Engl J Med; 2009 Jan; 360(2):186-7; author reply 187. PubMed ID: 19137625
    [No Abstract]   [Full Text] [Related]  

  • 27. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
    Doherty DE; Chapman KR; Martinez FJ; Belfer MH
    J Fam Pract; 2007 Oct; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
    [No Abstract]   [Full Text] [Related]  

  • 28. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
    Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
    Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium Respimat increases the risk of mortality.
    Jenkins CR; Beasley R
    Thorax; 2013 Jan; 68(1):5-7. PubMed ID: 23229813
    [No Abstract]   [Full Text] [Related]  

  • 30. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 33. Tiotropium in chronic obstructive pulmonary disease.
    Singh S; Furberg CD; Loke YK
    N Engl J Med; 2009 Jan; 360(2):186; author reply 187. PubMed ID: 19137626
    [No Abstract]   [Full Text] [Related]  

  • 34. Eppur si muove, or COPD treatment success and inflammation.
    Soriano JB; Barnes NC
    Eur Respir J; 2007 Sep; 30(3):409-10. PubMed ID: 17766630
    [No Abstract]   [Full Text] [Related]  

  • 35. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
    Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
    Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [No medication for COPD patients who do not stop smoking? "Fat diabetics are treated, too"].
    MMW Fortschr Med; 2003 Oct; 145(44):45. PubMed ID: 14655510
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome measurements in COPD: are we schizophrenic?
    Gross NJ
    Chest; 2003 May; 123(5):1325-7. PubMed ID: 12740238
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M; Dahl R; Kornmann O; Korn S; Lawrence D; McBryan D
    Respir Med; 2013 Feb; 107(2):223-32. PubMed ID: 23219347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.
    Vogelmeier C; Aquino TO; O'Brien CD; Perrett J; Gunawardena KA
    COPD; 2012 Apr; 9(2):111-20. PubMed ID: 22458939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.